NewsRack: 'india' news in 'IP' topic for user Genecampaign (21-41 of 4,155)

Infosys Q4 results trigger fall in shares (Cached)	12.4.2013	New Kerala: Sports India
Bangalore, Apr 12 : Infosys reported a 3.3 percent rise in its consolidated net profit to Rs. 2,394 crore for the Q4 that ended on March 31, 2013 and the in the quarter the revenues grew by 1.4 percent sequentially, said the IT bellwether as it announced results which failed to cheer the market and its shares fell impacting the stock market owing to unimpressive guidance.
Also found in: [+]
Indian patent rulings may face legal heat internationally (Cached)	11.4.2013	ET: Policy
Multinational drug makers, who have invested billions of dollars on research, are peeved with some of the recent court rulings in India
Also found in: [+]
Novartis case:Supreme Court ruling wise and balanced (Cached)	10.4.2013	Rediff: Interviews
Supreme Court is saying that consumers should not be forced to pay higher prices just because it is chemically a new drug unless there is a therapeutic benefit involved.
Also found in: [+]
'Novartis ruling: It is not an anti-patent judgement' (Cached)	10.4.2013	Rediff: Business
Supreme Court is saying that consumers should not be forced to pay higher prices just because it is chemically a new drug unless there is a therapeutic benefit involved.
Also found in: [+]
Universities should be hotbeds for innovation: Pranab (Cached)	9.4.2013	New Kerala: India News
Kurukshetra (Haryana), April 9 : Pointing out that India's balance sheet of innovations was not very encouraging, President Pranab Mukherjee Tuesday called upon universities and research and development centres to become hotbeds of innovations.
Also found in: [+]
Higher education faces challenge of quality: President (Cached)	9.4.2013	New Kerala: India News
Kurukshetra (Haryana), April 9 : Institutes of higher learning continue to be challenged by quality, President Pranab Mukherjee said here Tuesday.
Also found in: [+]
Column: What was the Novartis case really about? (Cached)	8.4.2013	Rediff: Business
The drug Glivec was a genuinely new and important discovery deserving of patent protection.
Also found in: [+]
VIDEO: Drugs investment 'will cease in India'	8.4.2013	BBC News: AsiaPacific
The head of Novartis India, Ranjit Shahani, has said the company was "disappointed" that India's Supreme Court refused to grant a patent for an updated version of its cancer drug Glivec.
Also found in: [+]
What was the Novartis case really about? (Cached)	8.4.2013	Rediff: Columns
The drug Glivec was a genuinely new and important discovery deserving of patent protection.
Also found in: [+]
भारत के ऊंचे पेटेंट स्तर से सबक ले पश्चिम (Cached)	8.4.2013	नवभारत टैम्स
भारत के ऊंचे पेटेंट स्तर से सबक ले पश्चिम
Also found in: [+]
Most big patented drugs skip India (Cached)	8.4.2013	TOI: Home
Big pharma may be crying hoarse over India’s “weak’’ intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country.
Also found in: [+]
VIDEO: Patent dilemma for India drugs firms	7.4.2013	BBC: Business
India introduced a new patent law in 2005, under which several multinational pharmaceutical firms have been denied protection for their medicines.
Also found in: [+]
SPECIAL: Why SC got it right on Novartis (Cached)	7.4.2013	Rediff: Business
The judgment will save taxpayers' money without hurting the pharma industry or R & D.
Also found in: [+]
Company profits depend on the 'welfare payments' they get from society \| Ha-Joon Chang	5.4.2013	Guardian: Comment is Free
The free market is a myth. From drug patents to quantitative easing, businesses make money because of state help Earlier this week, India's supreme court ruled that the country will not grant a patent to Novartis , the Swiss pharmaceutical company, for the cancer drug, Glivec. Being a new version of an existing drug, the ruling said, it does not deliver enough innovation to warrant a patent. Novartis condemned the ruling as "a setback for patients that will hinder medical progress for diseases without effective treatment options". This statement is rich coming from a company from Switzerland – a country that infamously had no patent law until 1888, half a century after its introduction in most rich capitalist countries. Even after 1888, Switzerland refused to award pharmaceutical and other chemical patents for two decades, the new patent law having stipulated that patents are granted only to "inventions that can be represented by mechanical models". The country introduced chemical patents ...
Also found in: [+]
Japan's Nikkei jumps above 13,000 (Cached)	5.4.2013	TOI: Intl Business
Japan's benchmark stock index surged above 13,000 for the first time in more than four years on Friday.
Also found in: [+]
Initial Cyprus plan to tax insured depositors 'not smart': ECB (Cached)	4.4.2013	TOI: Intl Business
European central Bank President Mario Dragi said on Thursday that Cyprus's initial decision to charge a levy on insured as well as uninsured banks depositors was a mistake.
Also found in: [+]
US jobless claims at four-month high, cast shadow over labor market	4.4.2013	Top Headlines - The Times of India
US jobless claims at four-month high, cast shadow over labor market
Also found in: [+]
Wal-Mart strains to keep aisles stocked fresh (Cached)	4.4.2013	TOI: Home
The retailer is facing low customer confidence after it cut so many workers that it cannot stock its shelves properly, according to some employees and industry analysts.
Also found in: [+]
Japan's central bank shocks with massive stimulus (Cached)	4.4.2013	TOI: Home
The Bank of Japan shocked markets on Thursday with a radical overhaul of its policymaking, adopting a new balance sheet target and pledging to double its government bond holdings in two years as it seeks to end nearly two decades of deflation.
Also found in: [+]
EU, Australia, Canada may follow India's Patent Law (Cached)	4.4.2013	TOI: India
EU, Australia, Canada may follow India's Patent Law
Also found in: [+]

21 to 40 of 4,175